Pseudobactins bounded iron nanoparticles for control of an antibiotic-resistant Pseudomonas aeruginosa ryn32

Area of Science:

• Microbiology
• Nanotechnology
• Biochemistry

Background:

• Pseudomonas aeruginosa exhibits significant antibiotic resistance, necessitating alternative treatment strategies.
• Iron nanoparticles (FeNPs) have emerged as potential antimicrobial agents.
• Pyoverdines (PVDs) are siderophores produced by P. aeruginosa for iron uptake.

Purpose of the Study:

• To investigate the antibacterial efficacy of iron nanoparticles (FeNPs) conjugated with pyoverdines (PVDs).
• To explore the mechanism of action for FeNP-PVD conjugates against antibiotic-resistant bacteria.

Main Methods:

• Selection and characterization of an antibiotic-resistant Pseudomonas aeruginosa strain (ryn32).
• Preparation and characterization of iron nanoparticles (FeNPs) with diameters of 30-50 nm.
• Optimization of PVDs production conditions (pH, temperature, carbon/nitrogen sources, fermentation time).
• Assessment of antibacterial activity of FeNP-PVD conjugates against P. aeruginosa and other gram-negative bacteria.

Main Results:

• FeNP-PVD conjugates demonstrated significant antibacterial action against the producing strain and other gram-negative bacteria.
• The conjugates appear to enter bacterial cells via the ferriPVDs uptake pathway.
• Iron accumulation within bacterial cells was observed, impacting bacterial viability.
• FeNPs and PVDs separately showed growth-stimulating effects at similar concentrations.

Conclusions:

• FeNP-PVD conjugates represent a promising strategy for combating antibiotic-resistant Pseudomonas aeruginosa.
• The ferriPVDs uptake pathway is a viable target for delivering nanoparticles into bacterial cells.
• Intracellular iron accumulation induced by FeNPs is a key factor in their bactericidal effect.